GlobeNewswire·Nov 11, 2026, 5:05 PM ET

Clairvest Reports Fiscal 2027 Second Quarter Results

Clairvest Group Inc. reported fiscal 2027 Q2 & six-month results ended September 30, 2026, with net income of $27.8 million ($2.08/share) for the quarter & $76.2 million ($5.69/share) for six months.
Book value per share increased 2.1% to $101.35 as at September 30, 2026, compared to $99.26 as at June 30, 2026.
Clairvest Equity Partners III ("CEP III") concluded with a final return of 2.5 times net for third-party investors, placing it in the top quartile of its vintage.
Clairvest & CEP VII completed two new investments totaling $73 million, with Clairvest's portion being $18 million in the food & beverage & medical practice management sectors.
The company purchased 2,800 common shares at an average price of $78.27 for a total cost of $0.2 million during the quarter.
Total available cash reached $294 million as at September 30, 2026, representing 22% of book value or approximately $22.01 per share.
CEP VII has made eight investments since 2024 & is currently 35% invested, with an expectation to substantially complete its program in 2027.
Net investment gains were $24.8 million for the quarter & $80.6 million for the six months, driven by increased valuations of the private equity portfolio.
Total assets stood at $1.54 billion as at September 30, 2026, while total liabilities were $184.5 million.
CEO Ken Rotman highlighted the completion of CEP III as a milestone & noted the active pipeline for building a high-quality CEP VII portfolio.